RGNX ▼ -2.5% - REGENXBIO Inc.
$RGNX RGNX - REGENXBIO Presents Positive Three-Year Durability Data for Surabgene Lomparvovec in Diabetic Retinopathy at Retina Society Annual Scientific Meeting
24-SEP-2026 07:19 PM ET
Share this post
More filings for $RGNX
RGNX ▲ +2.0% - REGENXBIO Inc.Nov 3, 2026RGNX ▼ -0.4% - REGENXBIO Inc.Oct 29, 2026RGNX - REGENXBIO Inc. - SEC Filing Update (13-OCT-2026) | ThinkSabio - Stocks SimplifiedOct 13, 2026RGNX ▲ +3.5% - REGENXBIO Inc.Oct 12, 2026RGNX ▲ +0.5% - REGENXBIO Inc.Oct 5, 2026RGNX ▼ -0.2% - REGENXBIO Inc.Sep 8, 2026
View full $RGNX filing history →💬 Comments
Loading comments…
Leave a comment